全文获取类型
收费全文 | 10478篇 |
免费 | 759篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 84篇 |
儿科学 | 217篇 |
妇产科学 | 81篇 |
基础医学 | 1190篇 |
口腔科学 | 231篇 |
临床医学 | 725篇 |
内科学 | 2883篇 |
皮肤病学 | 391篇 |
神经病学 | 578篇 |
特种医学 | 449篇 |
外科学 | 2115篇 |
综合类 | 47篇 |
一般理论 | 1篇 |
预防医学 | 284篇 |
眼科学 | 141篇 |
药学 | 542篇 |
中国医学 | 10篇 |
肿瘤学 | 1345篇 |
出版年
2024年 | 9篇 |
2023年 | 153篇 |
2022年 | 306篇 |
2021年 | 475篇 |
2020年 | 241篇 |
2019年 | 319篇 |
2018年 | 404篇 |
2017年 | 370篇 |
2016年 | 386篇 |
2015年 | 371篇 |
2014年 | 485篇 |
2013年 | 494篇 |
2012年 | 825篇 |
2011年 | 839篇 |
2010年 | 431篇 |
2009年 | 366篇 |
2008年 | 602篇 |
2007年 | 647篇 |
2006年 | 575篇 |
2005年 | 556篇 |
2004年 | 456篇 |
2003年 | 364篇 |
2002年 | 332篇 |
2001年 | 115篇 |
2000年 | 91篇 |
1999年 | 106篇 |
1998年 | 56篇 |
1997年 | 53篇 |
1996年 | 48篇 |
1995年 | 39篇 |
1994年 | 35篇 |
1993年 | 25篇 |
1992年 | 69篇 |
1991年 | 84篇 |
1990年 | 87篇 |
1989年 | 74篇 |
1988年 | 69篇 |
1987年 | 60篇 |
1986年 | 63篇 |
1985年 | 47篇 |
1984年 | 45篇 |
1983年 | 41篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1979年 | 19篇 |
1978年 | 13篇 |
1977年 | 15篇 |
1973年 | 3篇 |
1967年 | 4篇 |
1966年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Tsukamoto K Suzuki H Harada D Namba A Abe S Usami S 《European journal of human genetics : EJHG》2003,11(12):916-922
Molecular diagnosis makes a substantial contribution to precise diagnosis, subclassification, prognosis, and selection of therapy. Mutations in the PDS (SLC26A4) gene are known to be responsible for both Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct, and the molecular confirmation of the PDS gene has become important in the diagnosis of these conditions. In the present study, PDS mutation analysis confirmed that PDS mutations were present and significantly responsible in 90% of Pendred families, and in 78.1% of families with nonsyndromic hearing loss associated with enlarged vestibular aqueduct. Furthermore, variable phenotypic expression by the same combination of mutations indicated that these two conditions are part of a continuous category of disease. Interestingly, the PDS mutation spectrum in Japanese, including the seven novel mutations revealed by this study, is very different from that found in Caucasians. Of the novel mutations detected, 53% were the H723R mutation, suggesting a possible founder effect. Ethnic background is therefore presumably important and should be noted when genetic testing is being performed. The PDS gene mutation spectrum in Japanese may be representative of those in Eastern Asian populations and its elucidation is expected to facilitate the molecular diagnosis of a variety of diseases. 相似文献
62.
Keiko Wakui Toshiro Nishida Jun-ichiro Masuda Takeshi Itoh Daisuke Katsumata Tsutomu Ohno Yoshimitsu Fukushima 《Journal of human genetics》1991,36(2):149-153
We report a malformed female infant withde novo interstitial deletion of 4q[46,XX,del(4)(q27q28.2)]. The MN blood type analysis of the family members showed that the patient had an intact blood group-MN locus. The locus of the gene responsible for the MN antigen activity is confined to a 4q28.2–4q31.1 segment on the basis of the result of this patient and the previous mapping data. 相似文献
63.
Tanabe A Tsuiki M Watanabe D Takagi S Takano K Naruse M 《Rinsho byori. The Japanese journal of clinical pathology》2004,52(8):704-710
Aldosterone is one the representative cardiovascular hormones involved in the blood pressure and body-fluid homeostasis. Elevation of aldosterone leads to systemic hypertension through its action on the mineralocorticoid receptor (MR) in the kidney. More recent studies demonstrated that aldosterone may produce target organ damage through its direct actions on the non-epithelial MR of the heart in addition to its systemic effects. Clinical experience in primary aldosteronism supports the concept that aldosterone is a risk factor of cardiovascular complications, since concentric type of cardiac hypertrophy is most common in primary aldosteronism among various types of endocrine hypertension. Clinical mega-trial in congestive heart failure (RALES study, EPHESUS study) demonstrated blocking angiotensin II action is not sufficient for cardioprotection unless aldosterone action is equally blocked. An important phenomenon related to this issue is the aldosterone breakthrough which implies a reelevation of plasma aldosterone during chronic administration of ACE inhibitors and Angiotensin receptor antagonists. Normal level of aldosterone could still be a risk factor. Combination of ACE inhibitor or ARB with aldosterone antagonist could result in a better cardioprotection in cardiovascular diseases. Although spironolactone has been the only one aldosterone antagonist, a new antagonist eplerenone has been developed. Eplerenone is specific to MR and is practically devoid of the major side effect gynecomastia of spironolactone. Another topic of aldosterone is its very quick cardiovascular effect presumably via a non-genomic action. All these recent findings support that this adrenocortical steroid hormone is as important as angiotensin II. Determining aldosterone levels is therefore much morel important than before in the diagnosis and treatment of cardiovascular diseases. 相似文献
64.
Karine Bollérot Daisuke Sugiyama Virginie Escriou Rodolphe Gautier Samuel Tozer Daniel Scherman Thierry Jaffredo 《Developmental dynamics》2006,235(1):105-114
We report here a method that allows fast, efficient, and low-cost screening for gene function in the vascular system of the vertebrate embryo. Through intracardiac delivery of nucleic acids optimally compacted by a specific cationic lipid, we are able to induce in vivo endothelial cell-specific gain-of-function during development of the vascular network in the chick embryo. When the nucleic acids are delivered during the period of intraembryonic hematopoiesis, aortic hemangioblasts, the forerunners of the hematopoietic stem cells known to derive from the aortic endothelium, are also labeled. Similarly, we show that siRNA could be used to induce loss-of-function in vascular endothelial cells. This gene transfer technique was also applied to the mouse embryo with a high efficiency. The present method allows large-scale analysis and may represent a new and versatile tool for functional genomics. 相似文献
65.
66.
Miki Kaneko Toshikazu Uchida Mitsuhiko Moriyama Yasuyuki Arakawa Toshio Shikata Kenichiro Gotoh Satoaki Mima 《Journal of medical virology》1995,47(3):204-208
A pathogenic role of precore-defective mutation in the onset of fulminant hepatitis B has been suggested. However, precore-defective mutants do not always cause fulminant hepatitis B and are not always isolated from affected patients. These findings strongly suggest the presence of some additional important mutations outside the precore region in fulminant hepatitis. In the present investigation an attempt was made to sequence the X open reading frame of hepatitis B virus DNA isolated from seven patients with fulminant hepatitis B and five patients with acute hepatitis B. The latter were used as controls. Since the X open reading frame encodes the X protein and contains the core promoter/enhancer II complex, some critical mutations may enhance or disrupt the replication and expression of hepatitis B virus DNA leading to fulminant hepatitis. A C-to-T substitution was found at nucleotide (nt) 1655, an A-to-T substitution at nt 1764 and a G-to-A substitution at nt 1766 in 4, 5 and 5 patients, respectively, out of the seven with fulminant hepatitis. These substitutions were not recognized in the patients with acute hepatitis. These mutations might change the function of the X protein and core promoter/enhancer II complex. It is suggested, therefore, that these mutations, as well as the precore-defective mutation, may play an important role in the pathogenesis of fulminant hepatitis. © Wiley-Liss, Inc. 相似文献
67.
68.
69.
A novel factor was found in the medium conditioned by SV40-transformed human embryo fibroblasts, which stimulate concanavalin A-induced thymocyte DNA synthetic response. This activity was estimated to be 10-15 kD and divided into two activities by ion exchange chromatography. One of them is a protein molecule and the other is a glycoprotein. In addition, these activities are not derived from the growth factors reported previously such as interleukin 2 (Morgan, R., Ruscetti, F. and Gallo, R. C. (1976) Science 193, 1007-1008) and transforming growth factor (De Larco, J. E. and Todaro, G. J. (1978) Proc. Natl. Acad. Sci. U.S.A. 75, 4001-4005). 相似文献
70.
K Gotoh A Gouchi Y Akura N Tanaka K Orita 《International journal of immunopharmacology》1991,13(5):485-492
Lymphocyte infiltration into a tumor has been regarded as an expression of host immunity against cancer, but tumor-infiltrating lymphocytes (TIL) have little or no cytotoxicity. This study examined two different approaches to augment this low cytotoxicity. Firstly, biological response modifiers (OK-432, PSK) were injected into gastric cancer intralesionally. Intralesional injection of OK-432 or PSK significantly augmented the cytotoxicity of TIL. By the injection of OK-432, the ratio of OKT8-, Leu7-positive cells were increased in the TIL subset. In the second approach, TIL of gastric or pulmonary cancer patients were cultured with interleukin-2 (IL-2) in vitro. Co-culturing with IL-2 augmented the low cytotoxicity of TIL, and broad-reactive lymphokine-activated killer (LAK) cells were generated from TIL. 相似文献